Yves Vanrenterghem

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Flavio Vincenti, B Charpentier, Yves Vanrenterghem et al. · American Journal of Transplantation · 2010 · 946 citations

Medicine, Nephrology, Pharmacology +15

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients

Bert Bammens, Pieter Evenepoel, H. Keuleers et al. · Kidney International · 2006 · 381 citations

Medicine, Nephrology, Dialysis +10

Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation

Henrik Ekberg, Corrado Bernasconi, Hélio Tedesco‐Silva et al. · American Journal of Transplantation · 2009 · 333 citations · Full text

Medicine, Nephrology, Pharmacology +11

THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS

Yves Vanrenterghem, L Roels, P. Michielsen et al. · The Lancet · 1985 · 328 citations

Medicine, Nephrology, Surgery +10

Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey

Yves Vanrenterghem, Claudio Ponticelli, José María Morales et al. · American Journal of Transplantation · 2003 · 327 citations

Medicine, Hematology, Nephrology +14